Israelis find biomarker linking genome instability, cancer
Ubiquilin-4 protein biomarker provides critical information about cancer tumors and patients’ chances of responding to treatment.
Ubiquilin-4 protein biomarker provides critical information about cancer tumors and patients’ chances of responding to treatment.
Discovery could allow enhanced activity of the immune system to attack cancer cells, in particular in cases of lung cancer and melanoma.
Now going into clinical trials for specific types of cancer, Alpha Tau’s technology shows potential for treating any solid tumor.
Discovery might help multiple myeloma patients receive earlier and more precise treatment and prevent relapse.
Researchers at the Technion successfully shrank malignant tumors in mice by manipulating the brain’s reward system.
A new approach to identifying ‘signposts’ on malignant cells may help immune-system cells eliminate the skin cancer.
The new technique, developed by Israeli researchers, may improve survival rates and allow surgeons to remove more cancer cells than ever before.
Expertise in data science has pushed Israel to the forefront in devising technologies for predicting the best course of treatment for each patient.
Existing chemo treatments for adults are not effective in a child’s body. The new system invented in Israel introduces a promising alternative.
Israeli and American researchers successfully halted the growth of mesothelioma in model animals by inhibiting the heparanase enzyme.
Israel’s BGN Technologies and National Institute for Biotechnology in the Negev are seeking industry collaboration for further development.
Israeli scientist Rony Dahan thinks he knows why immunotherapy hasn’t reached its full potential, and he aims to do something about that.
Israeli scientists are exploring cannabis as a treatment, or even cure, for conditions ranging from cancer to Parkinson’s, asthma, insomnia, PTSD, epilepsy and IBS.
New-generation cytopathological staining platform could be a reliable diagnostic tool to help determine whether and when to perform a prostate biopsy.
Belong’s free app provides all the resources cancer patients need in one place.